Costs of care for persons with opioid dependence in commercial integrated health systems. - Wikidata - wikimedia - TriplyDB

Costs of care for persons with opioid dependence in commercial integrated health systems.

Costs of care for persons with opioid dependence in commercial integrated health systems.

http://www.wikidata.org/entity/Q34079752

about

Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film.Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.A qualitative study of the adoption of buprenorphine for opioid addiction treatment.Economic Evaluations of Opioid Use Disorder Interventions.Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement.Predictors of early dropout in outpatient buprenorphine/naloxone treatment.Advanced Practice Nurses: Increasing Access to Opioid Treatment by Expanding the Pool of Qualified Buprenorphine Prescribers.Promoting Adoption of Medication for Opioid and Alcohol Use Disorders Through System Change.A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone.

P2860

Q30277261-14AE6819-2037-485D-85D5-161052589F43 Q35751878-B5A3EF98-D4CC-4F12-9957-361169E1488C Q36619638-09D09AB4-D3B1-4CF9-9788-BA6EBDBEE3A1 Q37498637-E43B8DD7-AD0C-4D8B-9FAD-8B751706B666 Q38784603-B388761C-CA09-4680-97D2-49B890E62085 Q39162177-E13BAF5B-F66F-4881-A1D5-7FA650154E4F Q41034820-197CCEB4-BF5B-497E-8BE9-C44EA99CE5A3 Q44333648-D7C2B9C8-E2DB-4043-B79E-81CB6E00FD36 Q44349044-BA463C2C-9EE7-468C-AC68-F7B863289C49 Q47282815-930C7EDA-40F7-45B0-B2DA-198B7B47BA9A

P2860

Costs of care for persons with opioid dependence in commercial integrated health systems.

http://www.wikidata.org/entity/Q34079752

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Costs of care for persons with opioid dependence in commercial integrated health systems.

@ast

Costs of care for persons with opioid dependence in commercial integrated health systems.

@en

Costs of care for persons with opioid dependence in commercial integrated health systems.

@nl

type

label

Costs of care for persons with opioid dependence in commercial integrated health systems.

@ast

Costs of care for persons with opioid dependence in commercial integrated health systems.

@en

Costs of care for persons with opioid dependence in commercial integrated health systems.

@nl

prefLabel

Costs of care for persons with opioid dependence in commercial integrated health systems.

@ast

Costs of care for persons with opioid dependence in commercial integrated health systems.

@en

Costs of care for persons with opioid dependence in commercial integrated health systems.

@nl

P1433

Q34079752-9455E544-66FB-4462-9A49-29A7192D78A1

P1476

Q34079752-FDFB8259-A78E-4DE2-B1C8-786B1123B912

P2093

Q34079752-336176E9-0043-44A4-BF57-7B16C5D3EDDD

Q34079752-37EC5463-F163-41F9-B91A-6556DA49D090

Q34079752-46628758-85A1-46BC-BD92-2E4A2101AC72

Q34079752-93B6669E-10CB-43F4-90FF-63D85F97BD87

Q34079752-AA0FF744-FA09-4373-A2BB-12B24DD988AB

Q34079752-B8269F2D-DA87-488E-BC02-53E18EA963B1

Q34079752-C90E9C3E-C0AA-4138-884A-CA4B6043C678

Q34079752-E1696E9D-D610-4F38-8207-149E4EE553AA

P2860

Q34079752-18F46630-5063-40B8-BDE9-7632B4B48600

Q34079752-1B478485-D31B-4296-A79A-11197210C933

Q34079752-2173B4EB-FB9E-40BA-97EF-6ECBD8A7EBB0

Q34079752-221CD400-91B9-4FCF-8753-158311A223CE

Q34079752-23A325CA-D26A-482D-80B3-6BE1D8C38244

Q34079752-4A2A0380-9C2A-4B21-B8C0-42C4B20321CC

Q34079752-4C9A4E62-29B2-4A8D-A64D-1C4EFA10381C

Q34079752-66396622-0859-4811-824F-717989A78AB4

Q34079752-6EBF2686-0004-4BF8-B772-95148A6EC0BF

Q34079752-7E3F7C3F-FA4D-46EC-94D7-2D2E4E840B1A

P2888

Q34079752-E7AEFA2F-4614-470D-A995-F1D178B6C963

P304

Q34079752-DE03D251-4EF2-47C4-BB4B-E993CB438DE7

P31

Q34079752-095D2658-5FAF-45C0-BA94-818DC54E400F

P356

Q34079752-3A86C5B4-81B6-4556-91D1-9BC7AB822406

P407

Q34079752-68300FC5-69E1-4D4A-B704-742ECDAEA21C

P433

Q34079752-53788840-C04C-413E-832E-3EDAF5BEE110

P478

Q34079752-3A246864-23DB-464B-9FF1-4FFE1E063252

P50

Q34079752-EB5BCD98-C94E-47A8-BD47-C11AF74193BE

P577

Q34079752-9131C360-01AD-48C4-858A-D06252442388

P6179

Q34079752-38F1C9A2-86BF-4CE8-83F1-77B752170A91

P698

Q34079752-73F58280-F155-477E-87D7-D11CB95413A6

P921

Q34079752-4d62f09b-5d1c-4de6-bdc7-0a982e070d49

P932

Q34079752-138BD50A-5221-4C0B-8114-F0DDAD835026

P356

P1433

Addiction Science and Clinical Practice

P1476

Costs of care for persons with opioid dependence in commercial integrated health systems.

@en

P2093

Bradley M Anderson

http://www.w3.org/2001/XMLSchema#string

David Pating

http://www.w3.org/2001/XMLSchema#string

Dennis McCarty

http://www.w3.org/2001/XMLSchema#string

Frances L Lynch

http://www.w3.org/2001/XMLSchema#string

Jennifer Mertens

http://www.w3.org/2001/XMLSchema#string

John F Dickerson

http://www.w3.org/2001/XMLSchema#string

Nancy A Perrin

http://www.w3.org/2001/XMLSchema#string

Sujaya Parthasarathy

http://www.w3.org/2001/XMLSchema#string

P2860

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

The economic costs of heroin addiction in the United States.

Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial

A disease classification system for analysis of medical care utilization, with a note on symptom classification.

Family members of people with alcohol or drug dependence: health problems and medical cost compared to family members of people with diabetes and asthma.

Individuals receiving addiction treatment: are medical costs of their family members reduced?

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine.

Substance use and the quality of patient-provider communication in HIV clinics.

P2888

P304

16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1940-0640-9-16

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1019260646

http://www.w3.org/2001/XMLSchema#string

P698

25123823

http://www.w3.org/2001/XMLSchema#string

P921

P932

4142137

http://www.w3.org/2001/XMLSchema#string